Upregulation of <scp>ADAMDEC1</scp> correlates with tumor progression and predicts poor prognosis in non‐small cell lung cancer ( <scp>NSCLC</scp> ) via the <scp>PI3K</scp> / <scp>AKT</scp> pathway-Reference-Cited by-同舟云学术

Upregulation of ADAMDEC1 correlates with tumor progression and predicts poor prognosis in non‐small cell lung cancer ( NSCLC ) via the PI3K / AKT pathway

Published:2022-02-17 Issue:7 Volume:13 Page:1027-1039
ISSN:1759-7706
Container-title:Thoracic Cancer
language:en
Short-container-title:Thoracic Cancer

Author:

Zhu Weiliang¹,Shi Lin²,Gong Yuxin²,Zhuo Lin²,Wang Siyun²,Chen Shaobing²,Zhang Bei³,Ke Bin³^ORCID

Affiliation:

1. Department of Cancer Center Zhujiang Hospital of Southern Medical University Guangzhou Guangdong China

2. Department of Traditional Chinese Medicine Zhujiang Hospital of Southern Medical University Guangzhou Guangdong China

3. Department of VIP Region, State Key Laboratory of Oncology in South China Collaborative Innovation Center of Cancer Medicine, Sun Yat‐sen University Cancer Center Guangzhou Guangdong China

Funder

National Natural Science Foundation of China

Natural Science Foundation of Guangdong Province

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1759-7714.14354

Reference40 articles.

1. Epidemiology of Lung Cancer

2. Cancer statistics, 2020